Valiant Organics Limited has informed the Exchange regarding Outcome of Board Meeting held on May 16, 2026 w.r.t. re-appointment of Internal and Cost Auditor
VALIANTORG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Valiant Organics reported strong FY26 results with standalone net profit of Rs. 3,435.56 lakhs, turning around from a loss of Rs. 299.84 lakhs in FY25. Revenue from operations grew 2.7% to Rs. 73,838.31 lakhs. The company identified Pharma Business as a new reportable segment alongside Specialty Chemicals, with Pharma revenue rising 28% to Rs. 16,356.38 lakhs. The Board re-appointed Ketki D. Visariya as Cost Auditor and M/s. Manish Modi & Associates as Internal Auditor for FY26-27. Statutory auditors M/s. Gokhale & Sathe issued an un-modified opinion. The company also received Rs. 852.76 lakhs as fire insurance settlement for a 2022-23 incident, with Rs. 572.08 lakhs recognized as exceptional income.
Strong turnaround in profitability and expansion into pharma segment are positive signals for investors. The company's ability to return to profit from a loss position and diversify into pharma indicates improving business fundamentals.